- CBRE (Frankfort, KY)
- Business Development Director Job ID 219862 Posted...866 225 3099 (US) and +1 866 388 4346 ( Canada ). CBRE, Inc. is an Equal Opportunity and Affirmative ... education, training, and experience. The minimum salary for the Business Development Director position is $197,000 annually and the maximum salary for the_… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more
- CBRE (Frankfort, KY)
- Director , Business Development & Capital Markets...866 225 3099 (US) and +1 866 388 4346 ( Canada ). CBRE, Inc. is an Equal Opportunity and Affirmative ... Remote - US - Remote - US - United States of America ** Director , Business Development & Capital Markets - Energy and Renewables Advisory** **Remote | Preference… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more
- Sumitomo Pharma (Frankfort, KY)
- …based in Japan with key operations in the US (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada , Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) ... gene therapies. With several marketed products in the US, Canada , and Europe, and a diverse pipeline of early-...late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For… more